The agency is approaching the new overhaul as a chance to reshape drug regulations in the European Union.

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

The European Medicines Agency has welcomed a political agreement between EU institutions on a far-reaching reform of ...

Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...

Today, the European Medicines Agency’s Committee for Medicinal Products for Human Use, CHMP, issued a positive opinion for a ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera ...

ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...

CluePoints, provider of leading statistical and AI-driven software solutions, has won the 'Best Contract Research Organization– Specialist Providers' category at the 2025 Scrip Awards.

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

The second is a License Agreement granting Everest the exclusive license to develop, register and commercialize Lerodalcibep, a novel, small protein-binding, third-generation PCSK9 inhibitor, which is ...

Investing.com -- ImmunityBio (NASDAQ:IBRX) stock rose 3.9% Friday after the European Medicines Agency (EMA) recommended granting conditional marketing authorization for its bladder cancer therapy ...